A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
about
Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumorsDesign and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionOptimizing the Detection of Circulating Markers to Aid in Early Lung Cancer DetectionBiomarkers of risk to develop lung cancer in the new screening eraEpigenetics in non-small cell lung cancer: from basics to therapeuticsDiagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current LiteratureChemoprevention studies within lung cancer screening programmesGenomics of Cancer and a New Era for Cancer PreventionNon-coding RNAs in lung cancerMicroRNA, nutrition, and cancer preventionCirculating microRNAs in cancer: origin, function and applicationManagement of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational StudyCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCLung Cancer Gene Signatures and Clinical PerspectivesUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionAltered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infectionFrom randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue fraEvaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer.Assessment of the cancer risk factors of solitary pulmonary nodulesDiagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.Rank-based miRNA signatures for early cancer detection.Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.Pre-profiling factors influencing serum microRNA levelsMicroRNAs as lung cancer biomarkersMicroRNAs As Biomarkers For Clinical Features Of Lung CancerThe impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer researchComparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence.MicroRNA expression profiles of whole blood in lung adenocarcinomaCirculating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomiaNon-Coding RNAs: Functional Aspects and Diagnostic Utility in OncologyBridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraComparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.Potential biomarkers for lung cancer screeningCirculating miRNAs miR-34a and miR-150 associated with colorectal cancer progressionMicroRNA (miRNA) in cancerCirculating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.Circulating microRNAs: next-generation biomarkers for early lung cancer detection.
P2860
Q21134548-7575FF74-B1CA-40CB-8FFD-EBB42DD931DFQ24289207-F4341601-9C76-4CEA-83D7-C0AA21E23E3EQ26742027-704F4819-1E37-42F1-9592-C31DE97F5544Q26745560-251A4D04-A4EB-48CC-ABD2-B3AE79E956FBQ26747784-C9F49C14-97DC-4D19-A6FA-53CB312EF2F0Q26749113-EEB3D4F9-E2F7-4EDB-9E65-6ACED6B6C0DCQ26752611-D9344BD3-5B79-41FC-8349-571E19D97A99Q26774588-E01DAEDF-BF5C-404A-9DCC-6F64C29E72CEQ26779113-55F47ECD-862E-4869-BA15-F97F29C01A84Q26866521-FB228283-0FC1-4715-8E7A-F2295A2857C8Q27010206-32FEFAB0-EA43-4797-B6BB-F5C369E991DAQ27013716-09E4DC47-1C0A-4722-A712-E9CEE9C8D166Q27348798-362DA5C2-9B99-4016-A263-E6D4A1B927A4Q28073562-7601DCB0-FBA5-4E2F-AE63-AF0D318D3704Q28387769-2FE74D64-2FB4-4A0F-B154-6AFFA6E2F888Q28388931-E1C1DD6F-6F01-4C82-B822-C4AAD3168C03Q28709053-8892E789-9983-419C-959D-069C42CAA417Q30535897-D11DB218-E119-4551-98FC-4543FEF460C2Q33642738-BCFE89EE-2D60-4DE7-83F6-29194A9A3276Q33710108-0BA20C6A-44B2-42AA-9FD8-D315E410B5EEQ33737293-C9A1CAC9-501B-4737-9BE0-0F4DE58E0E83Q33865653-41B39D16-F0CB-45F4-93F2-4D52E7C40F0BQ33916362-B5865920-6993-4D0A-A739-B492FC046E79Q33936328-9C050835-7032-43E7-BA48-A5E357017FA8Q34031213-6C744281-001B-4CB9-AF3A-8933C0E28EE2Q34158964-1A9EA6D0-1BC0-4ED4-9D35-BB7505364F7CQ34252557-8C3D1907-19D2-4DC7-B464-5C4415C3B94AQ34410828-E8952350-9D75-413B-AD26-23A14E5B24D8Q34430694-ACBDF3CD-CE9C-4F2B-95C8-9574982D4F31Q34441361-89A870F4-E0CF-49C5-9B37-4C703EDDF837Q34599011-E5A142A9-B571-4CC6-8501-2B83EB9982AEQ34605730-4B35A08B-366A-49E6-B09D-4655F1EC5DA3Q34840130-7091E3B8-E034-4FA4-927C-351833A2219AQ35018941-B17B83E3-EADC-459F-8193-A3A3607BDD51Q35101278-9B34EC83-A71D-496D-86E6-183FC98A40C7Q35200580-32645ECB-3034-415B-BCBC-E82A4B6CF328Q35562364-E43C966A-5CB3-4DF0-B89A-E3B22EF487C2Q35583538-47DEE7FA-B449-4F90-926C-6CE971AFF45CQ35597752-D7390EAA-38AB-4CF5-97D2-1ED35313C820Q35883222-A5845099-4C13-4FBC-BC65-2F49C3BD3794
P2860
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A serum circulating miRNA diag ...... s with early stage lung cancer
@ast
A serum circulating miRNA diag ...... s with early stage lung cancer
@en
type
label
A serum circulating miRNA diag ...... s with early stage lung cancer
@ast
A serum circulating miRNA diag ...... s with early stage lung cancer
@en
prefLabel
A serum circulating miRNA diag ...... s with early stage lung cancer
@ast
A serum circulating miRNA diag ...... s with early stage lung cancer
@en
P2093
P2860
P50
P356
P1476
A serum circulating miRNA diag ...... s with early stage lung cancer
@en
P2093
Fabrizio Bianchi
Giuseppe Pelosi
Loris Bernard
Pier Paolo Di Fiore
Valentina Dall'olio
P2860
P304
P356
10.1002/EMMM.201100154
P577
2011-07-11T00:00:00Z